Public health implications of molecular point-of-care testing for chlamydia and gonorrhoea in remote primary care services in Australia: a qualitative study.

CONCLUSIONS: Results indicate a high level of support from clinicians and public health practitioners for wider access to CT/NG POC tests citing potential benefits, including earlier, more accurate treatment decisions and reductions in ongoing transmission. However, the data also highlight the need for new systems to avoid adverse impact on disease surveillance. TRIAL REGISTRATION NUMBER: Australian and New Zealand Clinical Trials Registry: ACTRN12613000808741. PMID: 25922100 [PubMed - indexed for MEDLINE]

http://www.ncbi.nlm.nih.gov/pubmed/25922100?dopt=Abstract

Source: Rural Remote Health - December 26, 2015 Category: Rural Health Authors: Natoli L, Guy RJ, Shephard M, Whiley D, Tabrizi SN, Ward J, Regan DG, Badman SG, Anderson DA, Kaldor J, Maher L, TTANGO investigator group Tags: BMJ Open Source Type: research